3-chloro-L-tyrosine has been researched along with deoxycytidine in 1 studies
Studies (3-chloro-L-tyrosine) | Trials (3-chloro-L-tyrosine) | Recent Studies (post-2010) (3-chloro-L-tyrosine) | Studies (deoxycytidine) | Trials (deoxycytidine) | Recent Studies (post-2010) (deoxycytidine) |
---|---|---|---|---|---|
81 | 1 | 26 | 18,160 | 4,652 | 8,898 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dedon, PC; Fox, JG; Kang, P; Knutson, CG; Korzenik, JR; Liberman, RG; Lu, K; Mangerich, A; Prestwich, EG; Raczynski, AR; Tannenbaum, SR; Wishnok, JS; Wogan, GN; Ye, W; Zeng, Y | 1 |
1 other study(ies) available for 3-chloro-L-tyrosine and deoxycytidine
Article | Year |
---|---|
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.
Topics: Acute-Phase Proteins; Animals; Biomarkers; Chemokines; Cytokines; Deoxycytidine; Disease Models, Animal; DNA Damage; DNA-Binding Proteins; Female; Helicobacter hepaticus; Helicobacter Infections; Humans; Immunity, Innate; Inflammatory Bowel Diseases; Male; Mice; Mice, Knockout; Tyrosine | 2013 |